Snapshot
Simply Good Foods Co reported $369M of revenue in Q4 2025, up -1.8% year over year, with diluted EPS of $-0.12 and an operating margin of -3.2%.
- Revenue
- $369M
- YoY growth
- +-1.8%
- Diluted EPS
- $-0.12
- Operating margin
- -3.2%
What management said
- •Today, Geoff Tanner, President and CEO, and Chris Bealer, CFO, will provide you with an overview of our results, which were provided in our earnings release issued earlier this morning.
- •Due to the company's asset-light, high cash flow business model, we evaluate our performance on an adjusted basis as it relates to EBITDA and diluted EPS.
- •The acquisition of Only What You Need, or OWYN, was completed on June 13, 2024.
- •As we have now lapped the anniversary date of the OWYN acquisition, the use of organic refers to year-over-year growth for brands we have owned for more than 12 months on a comparable basis.
- •We delivered 9% reported net sales growth, including 3% on an organic basis, and grew adjusted EBITDA by 3%.
- •On a pro forma basis, including OWYN, but excluding the extra week from the prior year, net sales increased over 4% with adjusted EBITDA up approximately 6%.
- •Our recent acquisition of OWYN enhanced our presence in the fast-growing ready-to-drink shake segment, while positioning us to become a leader of the rapidly accelerating clean label movement.
- •We ramped up productivity initiatives to combat inflation and free up funds to fuel our growth.
- •Overall, our fiscal year finished generally in line with our guidance, with some modestly higher costs impacting our margins as we exited the year.
- •Organic net sales grew at least 3% in each of the last three quarters.
- •Excluding the small contribution from OWYN prior to the anniversary date of the acquisition's closing, as well as the lap of the 53rd week, organic net sales grew 3.5%.
- •Excluding the inventory step-up related to the acquisition of OWYN, which was a 90 basis points headwind to gross margins in the fourth quarter of last year, gross margins declined 540 basis points.
What went well
- •Full fiscal year 2025 delivered 9% reported net sales growth (3% organic) and 3% adjusted EBITDA growth, with pro forma net sales up over 4% and adjusted EBITDA up about 6% excluding the prior-year extra week.
- •Quest grew 15.9% organically in Q4 and 13.4% for the full year, generating almost two-thirds of company net sales in Q4 and driven by strong salty snacks performance.
- •The nutritional snacking category grew 13% in fiscal 2025, mostly volume, and has grown at least high single digits for five years, supporting the high-protein, low-sugar shift management is positioned to lead.
- •The company paid off $150 million of debt (bringing total repayments since the OWYN acquisition to $240 million) and repurchased roughly $51 million of stock, ending the year at about 0.5x net debt to adjusted EBITDA.
- •The board approved a $150 million increase to the share repurchase program, leaving approximately $171 million of authorization remaining as of October 23, 2025.
- •OWYN integration progressed well with synergies on track, and the brand continued growing mid-teens despite the product quality issue, with household penetration up close to a point.
What went wrong
- •Q4 reported net sales declined 1.8% to $369 million, and Atkins fell 18.3% in Q4 (down 12.9% for the full year) on distribution losses and trade inventory reductions, especially at Club and Mass.
- •Q4 gross margin fell 450 basis points to 34.3% (540 bps excluding the prior-year OWYN inventory step-up) driven by elevated input costs, most notably cocoa contracted at historically high prices, plus tariffs.
- •A non-cash impairment of $60.9 million was recorded against the Atkins brand and related intangibles, reflecting fiscal 2025 performance and lower future revenue projections, producing a Q4 net loss of $12.4 million.
- •An OWYN product quality issue tied to pea protein raw material sourcing (a decision made before the acquisition closed) affected taste and texture on certain aged lots, impacting roughly 10% of product and weighing on consumption and ratings and reviews.
- •Adjusted EBITDA declined 14.5% in Q4 to $66.2 million (high single-digit decline excluding the extra week), and full-year cash flow from operations fell to $178 million from about $216 million on higher working capital use.
Guidance changes
| Metric | Period | Previous | Current | Change |
|---|---|---|---|---|
| Targeted pricing actions | FY2026 | — | In market by end of Q1 across all three brands; low single-digit benefit once fully implemented | new |
| Atkins net sales | FY2026 H1 | — | Down more than 20%, better in second half | new |
| Quest net sales | FY2026 | — | Up really high single digits | new |
| OWYN net sales | FY2026 | — | Double-digit range | new |
| Gross margin trajectory | FY2026 | — | Improving modestly in Q3, more meaningfully in Q4 as cocoa coverage shifts to lower rates | new |
Performance breakdown
| Metric | YoY change | Reason |
|---|---|---|
| Q4 reported net sales | -1.8% to $369M | Lapping the 53rd week and the OWYN pre-anniversary period; Atkins distribution losses partially offset by Quest growth. |
| Q4 organic net sales | +3.5% | Quest growth of 15.9% from strong salty snacks, partially offset by an 18.3% Atkins decline. |
| Q4 gross margin | -450 bps to 34.3% | Higher input costs, most notably cocoa, plus initial tariff impact, only partially offset by productivity and pricing. |
| Q4 adjusted EBITDA | -14.5% to $66.2M | Lower gross profit from inflation and the lap of the 53rd week. |
| Q4 selling and marketing expense | -20.6% to $32.4M | Planned pullback in Atkins marketing and lapping the 53rd week. |
| Full-year net sales | +9% | OWYN acquisition added nearly eight points, partially offset by about 2% from lapping the 53rd week. |
Earnings call themes & trends
| Topic | Previous mention | Current period | Trend |
|---|---|---|---|
| Atkins distribution rationalization | Ongoing shelf-space pressure discussed in prior periods | Tail SKUs trimmed; ~75% of sales from top-two-quartile SKUs; only ~10%-15% of SKUs in bottom quartile remain | ongoing |
| Cocoa and tariff inflation | — | High contracted cocoa prices and tariffs pressure margins into H1 FY2026; relief expected from Q3 as lower-cost coverage kicks in | peaking then easing |
| Category mainstreaming beyond the traditional aisle | — | High-protein/low-sugar demand expanding addressable market; investing in displays, club, and away-from-home channels | expanding |
| OWYN clean-label positioning | — | Product quality issue largely resolved with new formulation shipping since August; increased trade and marketing to restart trial | recovering |
| Quest momentum and innovation | — | Salty snacks/chips fastest-growing; capacity expanding for the second time in two years; new club distribution being phased through the year | expanding |
| Capital allocation | — | Buybacks, CapEx for capacity, and M&A treated as 'and not or'; $150M buyback increase approved; comfortable debt levels | active |
Q&A summary
How is the path forward for OWYN after the product quality issue, and what is the range of FY sales outcomes? (Peter Grom, UBS)
The pea protein quality issue affected about 10% of product and is largely behind them, with a more stable formulation shipping since August and full market presence by fiscal Q2; trade and marketing were increased to restart trial, and OWYN is guided to double-digit growth with strong confidence in the clean-label opportunity.
How do you handicap future competition, and is there any shift in appetite for M&A given the CapEx investment? (Steve Powers, Deutsche Bank)
Competition is not new in this high-growth category and the company counters it with R&D, sales capabilities, supply chain agility, and an insurgent mindset; capital priorities are unchanged and treated as 'and not or,' so buybacks, CapEx, and the right M&A opportunity all remain possible.
Does the flat midpoint top-line guide imply a deceleration in Quest, given Quest exited near 14% and OWYN was double-digit? (Robert Moskow, TD Cowen)
The math is roughly right — Quest up high single digits and OWYN double-digit, with Atkins consumption down about 20%; the guide reflects a not-yet-in-market price increase, first-half-weighted elasticity, lower Atkins trade inventory, and tough Quest/OWYN laps in the first half.
Are the top-two-quartile Atkins SKUs growing, and will the tail rationalization be mostly behind you after FY2026? (Megan Clapp, Morgan Stanley)
The majority of the top-two-quartile SKUs representing 75% of sales are growing and healthy; declines are concentrated in the tail, and the focus is on rationalizing the remaining 10%-15% of bottom-quartile SKUs toward a more sustainable core assortment.
How should elasticity be viewed on the upcoming price increase, and what is the rationale for the Atkins entry price point? (John Baumgartner, Mizuho)
Pricing is mid- to high-single-digit on portions of the portfolio with elasticity expected in line with history (initially higher, then burning off); the new four-pack lowers Atkins' absolute shelf price versus its prior five-pack and is early but bringing in new users.
What percentage of COGS is cocoa, and could margin relief come earlier or larger than Q3 if prices keep falling? (James Salera, Stephens)
Cocoa is in the mid-single-digit range of total cost; coverage is locked at high prices through the first half, transitioning to lower, year-over-year deflationary costs in Q3 and more so in Q4 into FY2027, with spot prices offering further potential favorability.